Acorda Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Acorda Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Acorda Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Acorda Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Acorda Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390261A1 | Application | Sustained release aminopyridine composition | A61K31/44; A61K31/4409; A61K47/12; A61K47/14; A61K47/38; A61K47/44; A61K9/20; A61K9/2054; A61K9/2077 | December 07, 2023 |
| FI1732548T4 | Grant | Methods of using sustained release aminopyridine compositions | A61K31/435; A61K31/44; A61K31/4409; A61K9/20; A61P17/02; A61P19/08; A61P21/00; A61P25/00; A61P25/28; A61P43/00 | November 30, 2023 |
| DK1732548T4 | Application | Fremgangsmåder til anvendelse af aminopyridin-depotpræparater | A61P21/00; A61P25/00; A61P17/02; A61K9/20; A61K31/4409; A61P19/08; A61K31/44; A61P43/00; A61P25/28; A61K31/435 | November 20, 2023 |
| CA3059180C | Grant | Sustained release compositions of 4-aminopyridine | A61K31/4409; A61K9/2866 | October 17, 2023 |
| CA2894031C | Grant | Devices and methods for puncturing a capsule to release a powdered medicament therefrom | A61M15/0028; A61M15/0035; A61M15/0041; A61M2202/064; A61P25/16 | October 03, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer